Примери за използване на Subgroup of patients на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Survival estimates were lower in the subgroup of patients with PAH secondary to systemic sclerosis.
In the subgroup of patients with recent symptom onset(<
In a subgroup of patients not receiving an ACE inhibitor(n=366),
There is accumulating evidence that a subgroup of patients is at an increased risk of developing hypersensitivity reactions.
Table 5 Efficacy for the overall study population and in a subgroup of patients currently using ULT
A subgroup analysis showed that no treatment effect was observed as compared to placebo on the 6-minute walk test in the subgroup of patients with secondary pulmonary hypertension.
prolonging life in the subgroup of patients with non-small cell lung cancer of the adenocarcinoma type.
In the subgroup of patients treated with fondaparinux
A similar reduction was achieved in the subgroup of patients concomitantly treated with LAMA(rate ratio:
In this small subgroup of patients(n=8), 0 of 6 patients in the idebenone group deteriorated to≥1.0 logMAR whereas 2 of 2 patients in the placebo group showed such a deterioration.
A subgroup of patients with baseline CrCl between 50
should not be used in this particular subgroup of patients, especially if they had recent surgery(within 30 days).
detailed by PI strata for the subgroup of patients with genotypically resistant strains in the Table below.
as for the overall population, a statistically significant improvement in CFS in favour of IKERVIS was observed in this subgroup of patients.
the data suggested that a larger treatment effect relative to placebo was seen in the subgroup of patients with moderate dementia associated with Parkinson's disease.
tofacitinib 10 mg twice daily in the subgroup of patients without prior TNF inhibitor failure.
Apo A-1 in the subgroup of patients on background statin.
Significant absolute death reduction was limited to the subgroup of patients with greater disease severity i.e. baseline APACHE II score≥25
The efficacy and safety of the recommended doses of alogliptin and metformin in a subgroup of patients with type 2 diabetes mellitus and≥65 years old were reviewed
In the subgroup of patients with hormone receptor-positive disease(n=545),